EBMcalc Logo
   INTRO    EQUATIONS    CRITERIA    DECISION    CONVERT    SPECIALTIES    REFS    SEARCH    NEW    CONTACT
 
  COVID-19 Severity by M-CHA(2)DS(2)-VASc Score

 
Input
 
CHF No (0)

Yes (1)
HTN No (0)

Yes (1)
Age  
Diabetes No (0)

Yes (1)
Gender Female (0)

Male (1)
CVA No (0)

Yes (2)
VascularDx No (0)

Yes (1)

 
Result
 
 
Score  
 

 
     
 
Include literature references: Yes   No

 
  M-CHA(2)DS(2)-VASc Score Interpretation

 
0 to 1 point: Low risk
2 to 3 points: Intermediate risk
4 to 9 points: High risk

 
 

 
Notes
  • This calculator represents findings from the literature referenced below. It is important to understand that these findings may not be representative of the experience in your local healthcare system.
  • In the Valente study[1], the CHA(2)DS(2)-VASc score is modified by reversing the point values for the Sex coefficient: females are assigned 0 points and males are assigned 1 point.
  • CHF: congestive heart failure; HTN: systemic hypertension; CVA: stroke; VascularDx: vascular disease.

 
Equations used
 
Score = AgeFactor + Gender + CHF + HTN + Diabetes + CVA + VascularDx

 

 
Calculation Details and Variables
  • Equation parameters such as CHF, have two or more discrete values that may be used in the calculation. The numbers in the parentheses, e.g. (0), represent the values that will be used.
  • AgeFactor is assigned values by this ordered logic:
    • If Age ≥75 yr AgeFactor = 2
    • Else if Age ≥65 yr AgeFactor = 1
    • Else AgeFactor = 0.

 
References
  1. Valente Silva B, Placido R, Jorge C, et al. Prognostic Accuracy of the Modified CHA2DS2-VASc Score in COVID-19 Patients Admitted to the Emergency Department Due to Clinical Worsening. Acta Med Port. 2021 Nov 26. PubMed ID: 34837357 PubMed Logo
  2. Olesen JB, Lip GY, Hansen ML, et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ. 2011 Jan 31;342:d124. doi: 10.1136/bmj.d124. PubMed ID: 21282258 PubMed Logo
  3. Lip GY, Halperin JL. Improving stroke risk stratification in atrial fibrillation. Am J Med. 2010 Jun;123(6):484-8. Review. PubMed ID: 20569748 PubMed Logo

 
Associated Medical Subject Headings [MeSH]
 
         Aged,   Atrial Fibrillation,   Female,   Fibrinolytic Agents,   Hospitalization,   Humans,   Incidence,   Kaplan-Meier Estimate,   Male,   Prognosis,   Risk Assessment,   Risk Factors,   Stroke,   Thromboembolism,   Vitamin K

 
Associated Logical Observation Identifiers Names and Codes [LOINC]
 
Parameter LOINC's and Suggested Units
Age 21612-7 : yr      21612-7 : yr      21612-7 : years      30525-0 : Years old      30525-0 : yr      30525-0 : years      

 
This material contains content from LOINC® (http://loinc.org). The LOINC table, LOINC codes, and LOINC panels and forms file are copyright © 1995-2014, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and available at no cost under the license at http://loinc.org/terms-of-use.

 
Associated ICD10-CM Codes
 
   I67.9Cerebrovascular disease, unspecified
   I48.91Unspecified atrial fibrillation

 
Associated ICD9-CM Codes
 
   427.31Atrial fibrillation
   437.9Cerebrovasc disease nos

 

 
Legal Notices and Disclaimer

 
All information contained in and produced by the EBMcalc system is provided for educational purposes only. This information should not be used for the diagnosis or treatment of any health problem or disease. THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER. Click here for full notice and disclaimer.
 
EBMcalc is Copyright © 1998-2022 Foundation Internet    [Build 265816 v22.1]